Guardant Health launches early-detection test for colon cancer

Bay Space biotech Guardant Well being introduced the industrial launch of its early-detection colon most cancers check on Monday, marking the most recent twist in an escalating race to identify most cancers sooner and extra precisely.

The corporate’s check, often known as Defend, is obtainable to adults 45 and older who aren’t updated with present screening tips, don’t have signs, and are at common danger of colon most cancers. Defend is a lab-developed check, which means that it hasn’t been accepted by the Meals and Drug Administration and that every pattern (a few tablespoon of blood) have to be despatched to Guardant’s lab.

Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!


Source link

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button